-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$5.00880.39% Upside
T2 Biosystems, Inc. Frequently Asked Questions
-
What analysts cover T2 Biosystems, Inc.?
T2 Biosystems, Inc. has been rated by research analysts at Canaccord Genuity in the past 90 days.